Multimorbidity

ST Skou, FS Mair, M Fortin, B Guthrie… - Nature Reviews …, 2022 - nature.com
Multimorbidity (two or more coexisting conditions in an individual) is a growing global
challenge with substantial effects on individuals, carers and society. Multimorbidity occurs a …

Polypharmacy: evaluating risks and deprescribing

AD Halli-Tierney, C Scarbrough, D Carroll - American family physician, 2019 - aafp.org
Polypharmacy, defined as regular use of at least five medications, is common in older adults
and younger at-risk populations and increases the risk of adverse medical outcomes. There …

Optimizing therapy to prevent avoidable hospital admissions in multimorbid older adults (OPERAM): cluster randomised controlled trial

MR Blum, BTGM Sallevelt, A Spinewine, D O'Mahony… - bmj, 2021 - bmj.com
Objective To examine the effect of optimising drug treatment on drug related hospital
admissions in older adults with multimorbidity and polypharmacy admitted to hospital …

Reducing inappropriate polypharmacy: the process of deprescribing

IA Scott, SN Hilmer, E Reeve, K Potter… - JAMA internal …, 2015 - jamanetwork.com
Inappropriate polypharmacy, especially in older people, imposes a substantial burden of
adverse drug events, ill health, disability, hospitalization, and even death. The single most …

A systematic review of the emerging definition of 'deprescribing'with network analysis: implications for future research and clinical practice.

E Reeve, D Gnjidic, J Long… - British journal of clinical …, 2015 - Wiley Online Library
Aims The aim of this study was to identify what definitions have been published for the term
'deprescribing', and determine whether a unifying definition could be reached. A secondary …

Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline

K Pottie, W Thompson, S Davies, J Grenier… - Canadian Family …, 2018 - cfp.ca
Objective To develop an evidence-based guideline to help clinicians make decisions about
when and how to safely taper and stop benzodiazepine receptor agonists (BZRAs); to focus …

The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta‐analysis

AT Page, RM Clifford, K Potter… - British journal of …, 2016 - Wiley Online Library
Aims Deprescribing is a suggested intervention to reverse the potential iatrogenic harms of
inappropriate polypharmacy. The review aimed to determine whether or not deprescribing is …

Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis

K Anderson, D Stowasser, C Freeman, I Scott - BMJ open, 2014 - bmjopen.bmj.com
Objective To synthesise qualitative studies that explore prescribers' perceived barriers and
enablers to minimising potentially inappropriate medications (PIMs) chronically prescribed …

Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action

E Reeve, W Thompson, B Farrell - European journal of internal medicine, 2017 - Elsevier
Deprescribing can be defined as the process of withdrawal or dose reduction of medications
which are considered inappropriate in an individual. The aim of this narrative review is to …

International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): position statement and 10 recommendations for action

D Mangin, G Bahat, BA Golomb, LH Mallery… - Drugs & aging, 2018 - Springer
Globally, the number of drug prescriptions is increasing causing more adverse drug events,
which is now a significant cause of mortality, morbidity, and disability that has reached …